China Biosimilar Drug Market Research Report 2016

September 2016 | 124 pages | ID: C7435D2CE48EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Biosimilar Drug

Revenue, means the sales value of Biosimilar Drug

This report studies Biosimilar Drug in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Hospira
• Sandoz
• Teva Pharmaceutical Industries
• Pfizer
• Merck Sharp & Dohme
• Celltrion
• Amgen
• Biogen
• Mylan
• Biocon
• Dr. Reddy’s Laboratories
• Boehringer Ingelheim GmbH
• Intas Pharmaceuticals
• LG Life Sciences
• Emcure Pharmaceuticals
• Probiomed
• Biosidus
• 3SBio
• WOCKHARDT
• Sun Pharmaceutical Industries
• Shanghai Fosun Pharmaceutical
• Qilu Pharmaceutical
• Allergan
• Dongbao
• Samsung Biologics
• Zydus Cadila.
• Dong-A Pharmaceutical

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by Application, this report focuses on consumption, market share and growth rate of Biosimilar Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

China Biosimilar Drug Market Research Report 2016

1 BIOSIMILAR DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Biosimilar Drug
1.2 Biosimilar Drug Segment by Type
  1.2.1 China Production Market Share of Biosimilar Drug Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Applications of Biosimilar Drug
  1.3.1 Biosimilar Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size (Value) of Biosimilar Drug (2011-2021)
1.5 China Biosimilar DrugStatus and Outlook
1.6 Government Policies

2 CHINA BIOSIMILAR DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 China Biosimilar Drug Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Biosimilar Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Biosimilar Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Biosimilar Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Biosimilar Drug Market Competitive Situation and Trends
  2.5.1 Biosimilar Drug Market Concentration Rate
  2.5.2 Biosimilar Drug Market Share of Top 3 and Top 5 Manufacturers

3 CHINA BIOSIMILAR DRUG MANUFACTURERS PROFILES/ANALYSIS

3.1 Hospira
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Biosimilar Drug Product Type, Application and Specification
    3.1.2.1 Type I
    3.1.2.2 Type II
  3.1.3 Hospira Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Sandoz
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 124 Product Type, Application and Specification
    3.2.2.1 Type I
    3.2.2.2 Type II
  3.2.3 Sandoz 124 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Teva Pharmaceutical Industries
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 129 Product Type, Application and Specification
    3.3.2.1 Type I
    3.3.2.2 Type II
  3.3.3 Teva Pharmaceutical Industries 129 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Pfizer
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Sept Product Type, Application and Specification
    3.4.2.1 Type I
    3.4.2.2 Type II
  3.4.3 Pfizer Sept Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Merck Sharp & Dohme
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Product Type, Application and Specification
    3.5.2.1 Type I
    3.5.2.2 Type II
  3.5.3 Merck Sharp & Dohme Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Celltrion
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Million USD Product Type, Application and Specification
    3.6.2.1 Type I
    3.6.2.2 Type II
  3.6.3 Celltrion Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Amgen
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Pharmaceuticals Product Type, Application and Specification
    3.7.2.1 Type I
    3.7.2.2 Type II
  3.7.3 Amgen Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 Biogen
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Product Type, Application and Specification
    3.8.2.1 Type I
    3.8.2.2 Type II
  3.8.3 Biogen Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 Mylan
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Product Type, Application and Specification
    3.9.2.1 Type I
    3.9.2.2 Type II
  3.9.3 Mylan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview
3.10 Biocon
  3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.10.2 Product Type, Application and Specification
    3.10.2.1 Type I
    3.10.2.2 Type II
  3.10.3 Biocon Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.10.4 Main Business/Business Overview
3.11 Dr. Reddy’s Laboratories
3.12 Boehringer Ingelheim GmbH
3.13 Intas Pharmaceuticals
3.14 LG Life Sciences
3.15 Emcure Pharmaceuticals
3.16 Probiomed
3.17 Biosidus
3.18 3SBio
3.19 WOCKHARDT
3.20 Sun Pharmaceutical Industries
3.21 Shanghai Fosun Pharmaceutical
3.22 Qilu Pharmaceutical
3.23 Allergan
3.24 Dongbao
3.25 Samsung Biologics
3.26 Zydus Cadila.
3.27 Dong-A Pharmaceutical

4 CHINA BIOSIMILAR DRUG CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Biosimilar Drug Capacity, Production and Growth (2011-2016)
4.2 China Biosimilar Drug Revenue and Growth (2011-2016)
4.3 China Biosimilar Drug Production, Consumption, Export and Import (2011-2016)

5 CHINA BIOSIMILAR DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Biosimilar Drug Production and Market Share by Type (2011-2016)
5.2 China Biosimilar Drug Revenue and Market Share by Type (2011-2016)
5.3 China Biosimilar Drug Price by Type (2011-2016)
5.4 China Biosimilar Drug Production Growth by Type (2011-2016)

6 CHINA BIOSIMILAR DRUG MARKET ANALYSIS BY APPLICATION

6.1 China Biosimilar Drug Consumption and Market Share by Application (2011-2016)
6.2 China Biosimilar Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 BIOSIMILAR DRUG MANUFACTURING COST ANALYSIS

7.1 Biosimilar Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilar Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biosimilar Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA BIOSIMILAR DRUG MARKET FORECAST (2016-2021)

11.1 China Biosimilar Drug Capacity, Production, Revenue Forecast (2016-2021)
11.2 China Biosimilar Drug Production, Import, Export and Consumption Forecast (2016-2021)
11.3 China Biosimilar Drug Production Forecast by Type (2016-2021)
11.4 China Biosimilar Drug Consumption Forecast by Application (2016-2021)
11.5 Biosimilar Drug Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biosimilar Drug
Figure China Production Market Share of Biosimilar Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Biosimilar Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure China Biosimilar Drug Revenue (Million USD) and Growth Rate (2011-2021)
Table China Biosimilar Drug Capacity of Key Manufacturers (2015 and 2016)
Table China Biosimilar Drug Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Biosimilar Drug Capacity of Key Manufacturers in 2015
Figure China Biosimilar Drug Capacity of Key Manufacturers in 2016
Table China Biosimilar Drug Production of Key Manufacturers (2015 and 2016)
Table China Biosimilar Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilar Drug Production Share by Manufacturers
Figure 2016 Biosimilar Drug Production Share by Manufacturers
Table China Biosimilar Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Biosimilar Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Biosimilar Drug Revenue Share by Manufacturers
Table 2016 China Biosimilar Drug Revenue Share by Manufacturers
Table China Market Biosimilar Drug Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Biosimilar Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Biosimilar Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Biosimilar Drug Product Type
Figure Biosimilar Drug Market Share of Top 3 Manufacturers
Figure Biosimilar Drug Market Share of Top 5 Manufacturers
Table Hospira Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hospira Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira Biosimilar Drug Market Share (2011-2016)
Table Sandoz Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sandoz Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sandoz Biosimilar Drug Market Share (2011-2016)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Industries Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceutical Industries Biosimilar Drug Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Biosimilar Drug Market Share (2011-2016)
Table Merck Sharp & Dohme Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Sharp & Dohme Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Sharp & Dohme Biosimilar Drug Market Share (2011-2016)
Table Celltrion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celltrion Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Celltrion Biosimilar Drug Market Share (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Biosimilar Drug Market Share (2011-2016)
Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Biosimilar Drug Market Share (2011-2016)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Mylan Biosimilar Drug Market Share (2011-2016)
Table Biocon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biocon Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biocon Biosimilar Drug Market Share (2011-2016)
Table Dr. Reddy’s Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dr. Reddy’s Laboratories Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Dr. Reddy’s Laboratories Biosimilar Drug Market Share (2011-2016)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim GmbH Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim GmbH Biosimilar Drug Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Intas Pharmaceuticals Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Intas Pharmaceuticals Biosimilar Drug Market Share (2011-2016)
Table LG Life Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LG Life Sciences Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure LG Life Sciences Biosimilar Drug Market Share (2011-2016)
Table Emcure Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emcure Pharmaceuticals Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Emcure Pharmaceuticals Biosimilar Drug Market Share (2011-2016)
Table Probiomed Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Probiomed Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Probiomed Biosimilar Drug Market Share (2011-2016)
Table Biosidus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biosidus Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biosidus Biosimilar Drug Market Share (2011-2016)
Table 3SBio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 3SBio Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure 3SBio Biosimilar Drug Market Share (2011-2016)
Table WOCKHARDT Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table WOCKHARDT Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure WOCKHARDT Biosimilar Drug Market Share (2011-2016)
Table Sun Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharmaceutical Industries Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sun Pharmaceutical Industries Biosimilar Drug Market Share (2011-2016)
Table Shanghai Fosun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shanghai Fosun Pharmaceutical Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Shanghai Fosun Pharmaceutical Biosimilar Drug Market Share (2011-2016)
Table Qilu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Qilu Pharmaceutical Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Qilu Pharmaceutical Biosimilar Drug Market Share (2011-2016)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Biosimilar Drug Market Share (2011-2016)
Table Dongbao Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dongbao Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Dongbao Biosimilar Drug Market Share (2011-2016)
Table Samsung Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Samsung Biologics Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Samsung Biologics Biosimilar Drug Market Share (2011-2016)
Table Zydus Cadila. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zydus Cadila. Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Zydus Cadila. Biosimilar Drug Market Share (2011-2016)
Table Dong-A Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dong-A Pharmaceutical Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Dong-A Pharmaceutical Biosimilar Drug Market Share (2011-2016)
Figure China Biosimilar Drug Capacity, Production and Growth (2011-2016)
Figure China Biosimilar Drug Revenue (Million USD) and Growth (2011-2016)
Table China Biosimilar Drug Production, Consumption, Export and Import (2011-2016)
Table China Biosimilar Drug Production by Type (2011-2016)
Table China Biosimilar Drug Production Share by Type (2011-2016)
Figure Production Market Share of Biosimilar Drug by Type (2011-2016)
Figure 2015 Production Market Share of Biosimilar Drug by Type
Table China Biosimilar Drug Revenue by Type (2011-2016)
Table China Biosimilar Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Biosimilar Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Biosimilar Drug by Type
Table China Biosimilar Drug Price by Type (2011-2016)
Figure China Biosimilar Drug Production Growth by Type (2011-2016)
Table China Biosimilar Drug Consumption by Application (2011-2016)
Table China Biosimilar Drug Consumption Market Share by Application (2011-2016)
Figure China Biosimilar Drug Consumption Market Share by Application in 2015
Table China Biosimilar Drug Consumption Growth Rate by Application (2011-2016)
Figure China Biosimilar Drug Consumption Growth Rate by Application (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure China Biosimilar Drug Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Biosimilar Drug Revenue and Growth Rate Forecast (2016-2021)
Table China Biosimilar Drug Production, Import, Export and Consumption Forecast (2016-2021)
Table China Biosimilar Drug Production Forecast by Type (2016-2021)
Table China Biosimilar Drug Consumption Forecast by Application (2016-2021)